Kinapse has provided advisory and operational services to the life sciences sector since it was started in 2005 by former Accenture consultants Andy Black, 48, and Nick Edwards, 54. It works with nine of the world’s top ten pharmaceutical companies, including Glaxo Smith Kline, Johnson & Johnson, Novartis, Pfizer and Bayer. The London firm generated three-quarters of its £20.8m sales this year from overseas markets and has offices in India and America, as well as in Britain. Synova Capital invested an undisclosed sum in 2012, becoming the largest shareholder.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
Year2015
Rank89
CompanyKinapse
ActivityPharmaceutical regulations consultancy
LocationSouthwest London
Annual sales rise over 3 years46.98%
Latest sales £000s20,839
Staff337
Founded2005
Websitewww.kinapse.com

If applicable:

* supplied by company † annualised figure